Company Filing History:
Years Active: 2002
Title: Paulus Jacobus Angelinus Krimpenfort: Innovator in Transgenic Research
Introduction
Paulus Jacobus Angelinus Krimpenfort is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of genetic engineering, particularly in the development of transgenic models for research purposes. His work has implications for understanding various biological processes and diseases.
Latest Patents
Krimpenfort holds a patent for "Transgenic mice depleted in a mature lymphocytic cell-type." This invention describes transgenic mice characterized by the substantial depletion of a specific mature lymphocytic cell type that naturally occurs in the species from which the transgenic mouse is derived. The phenotype is conferred by a transgene contained in at least the precursor stem cell of the lymphocytic cell type that is depleted. The transgene comprises a DNA sequence encoding a lymphatic polypeptide variant that inhibits the maturation of the lymphocytic cell type.
Career Highlights
Krimpenfort is associated with Genpharm International, Inc., where he has been involved in pioneering research and development in the field of transgenic technology. His work has contributed to advancements in genetic research and therapeutic applications.
Collaborations
One of his notable collaborators is Antonius Jozef Maria Berns. Together, they have worked on various projects that enhance the understanding of genetic modifications and their applications in biomedical research.
Conclusion
Paulus Jacobus Angelinus Krimpenfort's innovative work in transgenic research has paved the way for new discoveries in genetics and medicine. His contributions continue to influence the scientific community and advance the field of genetic engineering.